mkulltra58
New Member
Tren is low aromatizing not no aromatizing. You'll probably want to keep some test in there.
MESO-Rx
Anabolic Steroids
Tren is low aromatizing not no aromatizing. You'll probably want to keep some test in there.
Trenbolone does not aromatize.
Side Effects (Estrogenic):
Trenbolone is not aromatized by the body, and is not measurably estrogenic.
Excerpt From: Llewellyn, William. “Anabolics.” iBooks.
This material may be protected by copyright.
mkulltra58
New Member
I stand corrected. You still don't want to use tren alone.
You must UNLEARN. Lol @Dr JIM
Did he compare his situation to someone that won mr Olympia twice.
Chemical factoid ; Tren can NOT aromatize bc of the presence of double bonds in all three of it's rings
A fact MANY overlook. (Must be a "prolactin" thing again
)Perhaps even more important is although Nandrolone most certainly can increase
E-2, this effect is not mediated via peripheral aromatization.
Why is that important? AI's are not effective therapy for Nandrolone induced hyperestrogenemia!
jim
Last edited:
Chemical factoid ; Tren can NOT aromatize bc of the presence of double bonds in all three of it's rings
A fact MANY overlook. (Must be a "prolactin" thing again
Perhaps even more important is although Nandrolone most certainly can increase
E-2 this effect is not mediated via peripheral aromatization.
Why is that important? AI's are not effective therapy for Nandrolone induced hyperestrogenemia!
Llewellyn suggests using an AI to control aromatization from nandrolone. You're saying it won't work? If so, is that bc peripheral aromatization in adipose tissue for example is markedly less than testosterone for example? Isn't the liver where most of nandrolone's aromatization happens?
Wisps of reason overcome by ignorance, denial and a failure to heed the advice of those MUCH more experienced, has led to the problems your now confronting fella.
STOP CYCLING !!!
GOOD LUCK
I'd looked at his reference for that comment some time ago and it seemed to be a collective opinion with respect to peripheral aromatization of AAS in general, as peripheral aromatization is NOT a major contributor for the rise of E-2 noted with Nandrolone. (The reason is in some respects similar to Tren, Nandrolones chemical structure mandates a methylation step before oxidation can occur, and adipose tissue lacks that capability entirely)
Aromatization does occur within one of several hepatic cytochrome systems. Obviously then using a drug, such as an AI, that is primarily metabolized in the liver would pose considerable difficulties with respect to achieving effective INTRA-HEPATIC study state levels.
One means of overcoming this difficulty is to utilize drugs that possess significant second and/or third pass hepatic metabolism mechanisms. The latter has not been demonstrated to occur with reversible, non-steroidal AI's (at a level required) BUT this MAY be a benefit of irreversible steroidal AI's.
Admittedly I've not investigated the pharmacokinetics for the latter.
Last edited:
Any chance of pioneering a study to see exemestane vs arimidex or letro efficacy on nandrolone aromatization lol?
I also wonder if one were to make arimidex into an injectable preparation to bypass first pass, would this help?
I Declare WAR!
New Member
Nandrolone probably converts to estrogen, not through the action of aromatase, but through its 1-beta hydroxylated derivative. This means that estrogen inhibitors like Armidex, which decrease the activity of aromatase, may not stop nandrolone from aromatizing to estrogen.
Therefore, when one cycles nandrolone with testosterone, the combined amount of estrogen is greater. It is established that elevated levels of estrogen may lead to increased prolactin levels. Best to control the aromatization from testosterone at least when using nandrolone.
Can 19-nortestosterone derivatives be aromatized in the liver of adult humans? Are there clinical implications? - PubMed - NCBI
Therefore, when one cycles nandrolone with testosterone, the combined amount of estrogen is greater. It is established that elevated levels of estrogen may lead to increased prolactin levels. Best to control the aromatization from testosterone at least when using nandrolone.
Can 19-nortestosterone derivatives be aromatized in the liver of adult humans? Are there clinical implications? - PubMed - NCBI
Last edited:
I Declare WAR!
New Member
^ that linked article isn't directly related to the topic at hand but it does underscore the fact that the process is much more complex than it might seem at first glance.
One needs to consider reactions not just of the parent molecule but also pharmacology of the metabolites and their reactions with other enzymes, acids and bases in the body.
One needs to consider reactions not just of the parent molecule but also pharmacology of the metabolites and their reactions with other enzymes, acids and bases in the body.
1) Bc there are soooooo many questions that warrant further investigation, the task at this juncture is where, when, what and how research dollars are "best spent". The fact is bc the complications of AAS, other PEDs or ancillaries are readily PREVENTABLE research on on these compounds has taken a turn for the worse.
2) Oh your much more seasoned than that, bc essentially all drugs must pass thru Rome to reach the Mediterranean, metaphorically speaking, lol!
Last edited:
Hey DD I wasn't being sarcastic fella but to the contrary was only emphasizing my earlier point Hepatic entry, rather than bypass, is NEEDED for AI's to significantly influence the production of estrogen as a Nandrolone byproduct.
So the processes are competitive: on one end the liver is catabolizing the AI rendering it less effective BUT circumventing the hepatic system using a "bypass" mechanism limits the exposure of an AI to intra-hepatic aromatase. This is why several second or third order "bypass" are optimal as it allows the drug to accumulate WITHIN the hepatic sinusoids. I hope that makes sense ?
Bc the renal excretion (Mediterranean) of most drugs mandates a certain degree of enhanced water solubility a pass thru ROME (Liver) is a catabolic requirement. This will apply to AI's whether orally or parenterally administered.
Great questions fella!
JIM
Last edited:
That clarification makes much more sense. You want the drug to sit in the liver vs just bypassing it and re-enter systemic circulation.
Of course one huge problem inherent to such a process is the systemic concentration will often exceed the hepatic concentration several fold and result in intolerable toxicity.
As an aside that's one reason "chemo" is ineffective or MUCH less so, once
metastatic disease involves the liver.
Few drugs can hang out in the liver and not be metabolized by it SOONER rafter than later.
Jim
As an aside that's one reason "chemo" is ineffective or MUCH less so, once
metastatic disease involves the liver.
Few drugs can hang out in the liver and not be metabolized by it SOONER rafter than later.
Jim
Last edited:
Interact in what way, be specific!
Never mind this question was discussed at length but it's not to surprising you didn't "get it" !
GOOD LUCK
Never mind this question was discussed at length but it's not to surprising you didn't "get it" !
GOOD LUCK
Your spoon-feeding session has now ended, try a new approach, like READING for Godsake!
